Skip to main content
. Author manuscript; available in PMC: 2010 Dec 11.
Published in final edited form as: Vaccine. 2009 Oct 13;28(2):494–511. doi: 10.1016/j.vaccine.2009.09.133

Table 3.

Results of MPXV iv challenge

Monkey
ID
Group Vaccine Peak Lesion # Blood viremia
(genomes/ml)1
Throat swab
viremia
(genomes/ml)1
Disease Day of
Death
4306 1 pVEK 4pox 8 < 569,000 mild Survived
4307 1 pVEK 4pox 12 < 36,180 mild Survived
4308 1 pVEK 4pox 10 < 1,837,500 mild Survived
4309 1 pVEK 4pox 8 < 247,200 mild Survived
4310 1 pVEK 4pox 0 < 8,770 none Survived
4311 2 pERK 4pox 2 < 840,500 mild Survived
4312 2 pERK 4pox 8 < 390,000 mild Survived
4313 2 pERK 4pox 4 < 25,370 mild Survived
4314 2 pERK 4pox 0 < 1,123,000 none Survived
4315 2 pERK 4pox 12 <6500 10,306,890 mild Survived
4316 3 pVEK flu
HA
TNTC† 338,900 13,770,000 grave 9
4317 3 pVEK flu
HA
105 1,044,990 25,360,000 severe Survived
4318 3 pVEK flu
HA
TNTC 660,000 12,540,000 severe Survived
4319 4 pVEK flu
HA
TNTC† 981,000 83,100,000 grave 9
4320 4 pVEK flu
HA
TNTC† 9,915,000 4,250,000 grave 12
4321 4 pVEK flu
HA
TNTC 5,160,000 3,351,000 grave 12
4322 5 Dryvax 0 < 84,800 none Survived
4323 5 Dryvax 0 < 136,500 none Survived
1

mean of two highest consecutive time points

†

moribund animal euthanized

na, not applicable

TNTC= Too numerous to count

< no genome detected (<5000 genomes/ml)